Exosomes and the MICA-NKG2D system in cancer
- 20 April 2005
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 34 (3) , 206-213
- https://doi.org/10.1016/j.bcmd.2005.03.003
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- UL16 binding proteinsImmunobiology, 2004
- Downregulation and/or Release of NKG2D Ligands as Immune Evasion Strategy of Human NeuroblastomaNeoplasia, 2004
- Two Human ULBP/RAET1 Molecules with Transmembrane Regions Are Ligands for NKG2DThe Journal of Immunology, 2004
- Ovarian Carcinoma Expresses the NKG2D Ligand Letal and Promotes the Survival and Expansion of CD28− Antitumor T CellsCancer Research, 2004
- Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infectionTissue Antigens, 2004
- Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemiaBlood, 2003
- ULBP4 is a novel ligand for human NKG2DBiochemical and Biophysical Research Communications, 2003
- Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoproteinEuropean Journal of Immunology, 2002
- Malignant effusions and immunogenic tumour-derived exosomesThe Lancet, 2002
- ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D ReceptorPublished by Elsevier ,2001